Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
83.29
+3.81 (4.79%)
At close: Mar 31, 2026, 4:00 PM EDT
83.60
+0.31 (0.37%)
Pre-market: Apr 1, 2026, 6:03 AM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.8 billion as of April 1, 2026. Its market cap has increased by 203.58% in one year.
Market Cap
6.80B
Enterprise Value
5.26B
1-Year Change
203.58%
Ranking
Category
Stock Price
$83.29
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.80B, an increase of 714.88%. That is a compound annual growth rate of 45.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 6.80B | 9.24% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 7.89B |
| Halozyme Therapeutics | 7.66B |
| Krystal Biotech | 7.55B |
| Arcellx | 6.74B |
| Protagonist Therapeutics | 6.73B |
| Belite Bio | 6.27B |
| Apogee Therapeutics | 6.22B |
| Cogent Biosciences | 6.20B |